{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T19:20:02Z","timestamp":1789154402818,"version":"build-2803163510"},"reference-count":34,"publisher":"Japanese Society of Internal Medicine","issue":"19","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2025,10,1]]},"DOI":"10.2169\/internalmedicine.4376-24","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T18:11:57Z","timestamp":1743790317000},"page":"2852-2857","source":"Crossref","is-referenced-by-count":2,"title":["Small Intestinal Bacterial Overgrowth in a Healthy Female Patient Caused by Long-term Oral Proton Pump Inhibitor Administration"],"prefix":"10.2169","volume":"64","author":[{"given":"Koichi","family":"Soga","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Dokkyo Medical University Saitama Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sotaro","family":"Yamada","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Dokkyo Medical University Saitama Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuto","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Dokkyo Medical University Saitama Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumi","family":"Kusano","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Dokkyo Medical University Saitama Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuhiro","family":"Kobori","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Dokkyo Medical University Saitama Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasumi","family":"Katayama","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Dokkyo Medical University Saitama Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaya","family":"Tamano","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Dokkyo Medical University Saitama Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Pimentel M, Saad RJ, Long MD, Rao SSC. ACG clinical guideline: small intestinal bacterial overgrowth. Am J Gastroenterol 115: 165-178, 2020.","DOI":"10.14309\/ajg.0000000000000501"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Sachdev AH, Pimentel M. Antibiotics for irritable bowel syndrome: rationale and current evidence. Curr Gastroenterol Rep 14: 439-445, 2012.","DOI":"10.1007\/s11894-012-0284-2"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Ghoshal UC, Ghoshal U. Small intestinal bacterial overgrowth and other intestinal disorders. Gastroenterol Clin North Am 46: 103-120, 2017.","DOI":"10.1016\/j.gtc.2016.09.008"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Jandhyala SM, Talukdar R, Subramanyam C, Vuyyuru H, Sasikala M, Nageshwar Reddy D. Role of the normal gut microbiota. World J Gastroenterol 21: 8787-8803, 2015.","DOI":"10.3748\/wjg.v21.i29.8787"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Beliz\u00e1rio JE, Faintuch J, Garay-Malpartida M. Gut microbiome dysbiosis and immunometabolism: new frontiers for treatment of metabolic diseases. Mediators Inflamm 2018: 2037838, 2018.","DOI":"10.1155\/2018\/2037838"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Freedberg DE, Lebwohl B, Abrams JA. The impact of proton pump inhibitors on the human gastrointestinal microbiome. Clin Lab Med 34: 771-785, 2014.","DOI":"10.1016\/j.cll.2014.08.008"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Singh A, Cresci GA, Kirby DF. Proton pump inhibitors: risks and rewards and emerging consequences to the gut microbiome. Nutr Clin Pract 33: 614-624, 2018.","DOI":"10.1002\/ncp.10181"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Bushyhead D, Quigley EMM. Small intestinal bacterial overgrowth-pathophysiology and its implications for definition and management. Gastroenterology 163: 593-607, 2022.","DOI":"10.1053\/j.gastro.2022.04.002"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Skrzyd\u0142o-Radoma\u0144ska B, Cukrowska B. How to recognize and treat small intestinal bacterial overgrowth? J Clin Med 11: 6017, 2022.","DOI":"10.3390\/jcm11206017"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Ivashkin VT, Maev IV, Abdulganieva DI, et al. Practical Recommendation of the Scientific community for Human Microbiome Research (CHMR) and the Russian Gastroenterological Association (RGA) on small intestinal bacterial overgrowth in adults. Russ J Gastroenterol Hepatol Coloproctol 32: 68-85, 2022.","DOI":"10.22416\/1382-4376-2022-32-3-68-85"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Neale G, Gompertz D, Sch\u00f6nsby H, Tabaqchali S, Booth CC. The metabolic and nutritional consequences of bacterial overgrowth in the small intestine. Am J Clin Nutr 25: 1409-1417, 1972.","DOI":"10.1093\/ajcn\/25.12.1409"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Krajicek EJ, Hansel SL. Small intestinal bacterial overgrowth: a primary care review. Mayo Clin Proc 91: 1828-1833, 2016.","DOI":"10.1016\/j.mayocp.2016.07.025"},{"key":"13","first-page":"e8860","volume":"12","author":"TGO Achufusi","year":"2020","unstructured":"13. Achufusi TGO, Sharma A, Zamora EA, Manocha D. Small intestinal bacterial overgrowth: comprehensive review of diagnosis, prevention, and treatment methods. Cureus 12: e8860, 2020.","journal-title":"Cureus","ISSN":"https:\/\/id.crossref.org\/issn\/2168-8184","issn-type":"print"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Grace E, Shaw C, Whelan K, Andreyev HJN. Review article: small intestinal bacterial overgrowth - prevalence, clinical features, current and developing diagnostic tests, and treatment. Aliment Pharmacol Ther 38: 674-688, 2013.","DOI":"10.1111\/apt.12456"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Takakura W, Pimentel M. Small intestinal bacterial overgrowth and irritable bowel syndrome - an update. Front Psychiatry 11: 664, 2020.","DOI":"10.3389\/fpsyt.2020.00664"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Leite G, Rezaie A, Mathur R, et al; the REIMAGINE Study Group. Defining small intestinal bacterial overgrowth by culture and high throughput sequencing. Clin Gastroenterol Hepatol 22: 259-270, 2024.","DOI":"10.1016\/j.cgh.2023.06.001"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Simeonova D, Ivanovska M, Murdjeva M, Carvalho AF, Maes M. Recognizing the leaky gut as a trans-diagnostic target for neuroimmune disorders using clinical chemistry and molecular immunology assays. Curr Top Med Chem 18: 1641-1655, 2018.","DOI":"10.2174\/1568026618666181115100610"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Compare D, Sgamato C, Rocco A, Coccoli P, Ambrosio C, Nardone G. The leaky gut and human diseases: "can't fill the cup if you don't plug the holes first.". Dig Dis 24: 548-566, 2024.","DOI":"10.1159\/000540379"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19. Banaszak M, G\u00f3rna I, Wo\u017aniak D, Przys\u0142awski J, Drzyma\u0142a-Czy\u017c S. Association between gut dysbiosis and the occurrence of SIBO, LIBO, SIFO and IMO. Microorganisms 11: 573, 2023.","DOI":"10.3390\/microorganisms11030573"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Erdogan A, Rao SS. Small intestinal fungal overgrowth. Curr Gastroenterol Rep 17: 16, 2015.","DOI":"10.1007\/s11894-015-0436-2"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Jacobs C, Coss Adame E, Attaluri A, Valestin J, Rao SS. Dysmotility and proton pump inhibitor use are independent risk factors for small intestinal bacterial and\/or fungal overgrowth. Aliment Pharmacol Ther 37: 1103-1111, 2013.","DOI":"10.1111\/apt.12304"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Lombardo L, Foti M, Ruggia O, Chiecchio A. Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy. Clin Gastroenterol Hepatol 8: 504-508, 2010.","DOI":"10.1016\/j.cgh.2009.12.022"},{"key":"23","unstructured":"23. Zhang R, Li Y, Ma JX, Tang S, Li CM, Wan J. [The effects of continuous proton pump inhibitor therapy on small intestinal bacterial overgrowth in elderly]. Zhonghua Nei Ke Za Zhi 59: 706-710, 2020."},{"key":"24","doi-asserted-by":"publisher","unstructured":"24. Faulk DL, Anuras S, Christensen J. Chronic intestinal pseudoobstruction. Gastroenterology 74: 922-931, 1978.","DOI":"10.1016\/0016-5085(78)90156-7"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Downes TJ, Cheruvu MS, Karunaratne TB, De Giorgio R, Farmer AD. Pathophysiology, diagnosis, and management of chronic intestinal pseudo-obstruction. J Clin Gastroenterol 52: 477-489, 2018.","DOI":"10.1097\/MCG.0000000000001047"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Lauro A, De Giorgio R, Pinna AD. Advancement in the clinical management of intestinal pseudo-obstruction. Expert Rev Gastroenterol Hepatol 9: 197-208, 2015.","DOI":"10.1586\/17474124.2014.940317"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Ohkubo H, Kessoku T, Fuyuki A, et al. Assessment of small bowel motility in patients with chronic intestinal pseudo-obstruction using cine-MRI. Am J Gastroenterol 108: 1130-1139, 2013.","DOI":"10.1038\/ajg.2013.57"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Fuyuki A, Ohkubo H, Higurashi T, et al. Clinical importance of cine-MRI assessment of small bowel motility in patients with chronic intestinal pseudo-obstruction: a retrospective study of 33 patients. J Gastroenterol 52: 577-584, 2017.","DOI":"10.1007\/s00535-016-1251-8"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Begley M, Gahan CG, Hill C. The interaction between bacteria and bile. FEMS Microbiol Rev 29: 625-651, 2005.","DOI":"10.1016\/j.femsre.2004.09.003"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Avela Rodriguez D, Ryan PM, Toro Monjaraz EM, Ramirez Mayans JA, Quigley EM. Small intestinal bacterial overgrowth in children: a state-of-the-art review. Front Pediatr 7: 363, 2019.","DOI":"10.3389\/fped.2019.00363"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Ridlon JM, Kang DJ, Hylemon PB. Bile salt biotransformations by human intestinal bacteria. J Lipid Res 47: 241-259, 2006.","DOI":"10.1194\/jlr.R500013-JLR200"},{"key":"32","doi-asserted-by":"publisher","unstructured":"32. Ch\u00e1vez-Talavera O, Tailleux A, Lefebvre P, Staels B. Bile acid control of metabolism and inflammation in obesity, type 2 diabetes, dyslipidemia, and nonalcoholic fatty liver disease. Gastroenterology 152: 1679-1694.e3, 2017.","DOI":"10.1053\/j.gastro.2017.01.055"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Fleishman JS, Kumar S. Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets. Signal Transduct Target Ther 9: 97, 2024.","DOI":"10.1038\/s41392-024-01811-6"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Li T, Chiang JY. Bile acid signaling in metabolic disease and drug therapy. Pharmacol Rev 66: 948-983, 2014.","DOI":"10.1124\/pr.113.008201"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/19\/64_4376-24\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T03:20:19Z","timestamp":1759548019000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/19\/64_4376-24\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":34,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4376-24","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,1]]},"article-number":"4376-24"}}